Sydney, February 24, 2026, 16:56 AEDT — The session wrapped up, market now closed.

CSL Ltd closed down 1.5% on Tuesday at A$145.13, slipping from an open of A$148.10 before ending the day on the session’s low. The stock has now dropped 5.3% across the last two sessions. (Investing.com)

The drop adds to the strain on CSL, one of Australia’s largest healthcare firms, as fund managers puzzle over what counts as a “normal” trading day for the stock now. Buyback activity holds steady; volatility, though, hasn’t let up.

CSL posted an 81% plunge in first-half profit earlier this month, hit by softer blood plasma and vaccine sales plus some one-off charges. The company named director Gordon Naylor as interim CEO…